Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Commentary

Commentary: Research Highlights ATF4: The Perpetrator in Axonal-Mediated Neurodegeneration in Alzheimer's Disease

Author(s): S.M. Fayaz and G.K. Rajanikant

Volume 13, Issue 9, 2014

Page: [1483 - 1484] Pages: 2

DOI: 10.2174/1871527313666141110125829

Next »

Rights & Permissions Print Cite

Article Metrics

46

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
Current Genomics

The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Current Pharmaceutical Design

Stem Cells for the Treatment of Neurological Disorders
CNS & Neurological Disorders - Drug Targets

Gene Therapy for Neuroprotection and Neurorestoration (Part I)
Current Gene Therapy

Current Clinical Applications of In Vivo Magnetic Resonance Spectroscopy and Spectroscopic Imaging
Current Medical Imaging

The Bax Inhibitor-1 (BI-1) Family in Apoptosis and Tumorigenesis
Current Molecular Medicine

Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry

The Variable Presentations of Glycogen Storage Disease Type IV: A Review of Clinical, Enzymatic and Molecular Studies
Current Molecular Medicine

Establishment of a Secondary Screening Assay for P/Q-Type Calcium Channel Blockers
Combinatorial Chemistry & High Throughput Screening

Single Amino Acid Repeats Connect Viruses to Neurodegeneration
Current Drug Discovery Technologies

Neuroprotection: The Emerging Concept of Restorative Neural Stem Cell Biology for the Treatment of Neurodegenerative Diseases
Current Neuropharmacology

Gene and Cell Therapy for Prion Diseases
Infectious Disorders - Drug Targets

NSAID Use and the Risk of Parkinsons Disease
Current Drug Safety

Heat Shock Proteins: Mediators of Atherosclerotic Development
Current Drug Targets

Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins
Current Pharmaceutical Design

Development of Radioligands for Imaging of Brain Norepinephrine Transporters In Vivo with Positron Emission Tomography
Current Topics in Medicinal Chemistry

Re-Wiring the Circuit: Mitochondria as a Pharmacological Target in Liver Disease
Current Medicinal Chemistry

Bioinformatics and Protein Design
Current Pharmaceutical Biotechnology

The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review
CNS & Neurological Disorders - Drug Targets

Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles
Current Gene Therapy

© 2024 Bentham Science Publishers | Privacy Policy